Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Pterocarpus erinaceus extract is a plant-derived preparation obtained from various parts (primarily bark, root, leaf, and heartwood) of Pterocarpus erinaceus, a medicinal tree widely used in West African traditional medicine. Extracts contain multiple biologically active compounds, including flavonoids, terpenoids, phenols, alkaloids, tannins, phytate, triterpenes (e.g. friedelin, lupeol), and epicatechin. Pharmacological studies have demonstrated antioxidant, anti-inflammatory, analgesic, antibacterial, antifungal, and potentially neuroprotective activities. In vitro and in vivo models suggest inhibition of lipoxygenase, suppression of lipid peroxidation, and scavenging of free radicals[1][2][5][6][8]. There is also preliminary evidence the "kino" extract may act as a selective γ-secretase inhibitor, potentially relevant to Alzheimer's disease therapy[5]. These findings support its traditional use for conditions such as inflammation, pain, gastrointestinal disorders, infections, and possibly cognitive disorders.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Pterocarpus erinaceus extract.